Your session is about to expire
← Back to Search
Improved Opioid-Tapering Instructions for Osteoarthritis
Study Summary
This trial is testing whether a patient-maintained opioid diary, improved patient educational materials, and using a pain management counselor provides benefits in decreasing narcotic consumption, pain levels, nausea, sleep quality, and patient satisfaction.
- Osteoarthritis of the Knee
- Opioid Addiction
- Chronic Knee Pain
- Opioid Use Disorder
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What are the perils associated with Improved Opioid-Tapering Instructions for individuals?
"This phase 4 trial has been approved by the governing body, so we rate its safety as a 3 on our scale."
Is this research endeavor still recruiting participants?
"The trial information posted on clinicaltrials.gov reveals that this specific medical experiment is no longer recruiting patients, with its first post dating back to June 6th 2022 and the latest edit being done in September 10th 2021. Nevertheless, there are 876 other clinical trials currently accepting participants at present."
What aims are the researchers hoping to achieve through this clinical trial?
"This trial's primary goal is to measure opioid usage one week after surgery, with secondary objectives including a Visual Analogue Scale (VAS) assessment of surgical site pain and nausea as well as the percentage of patients who have finished taking opioids two weeks post-operation. This will all be observed over roughly 2-3 months or whenever necessary."
Share this study with friends
Copy Link
Messenger